Read More Analyst Color Analyst Ratings Long Ideas News Price Target Top Stories Trading Ideas Upgrades Goldman Sachs Sees Outperformance Ahead For Chevron: Here’s Why By Adam Eckert July 31, 10:36 AM Goldman Sachs has turned positive on Chevron Corp (NYSE: CVX) again. CVX
Read More Biotech General News RenovoRx Engages Oklahoma University Health As First Clinical Site In Preparation For The Pivotal Phase III CouGar Clinical Trial In Bile Duct Cancer By Benzinga Newsdesk December 21, 9:33 AM This study will be the Second Clinical Trial Evaluating RenovoGem™, a Combination Drug-Device Product, in a Difficult-to-Access Solid Tumor CancerRenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a RNXT
Read More Legal News Biogen Rejected By Supreme Court On Reviving Tecfidera Patent By Benzinga Newsdesk October 3, 9:41 AM -Bloomberg BIIB
Read More Analyst Ratings News Price Target Morgan Stanley Maintains Underweight on Walgreens Boots Alliance, Lowers Price Target to $37 By Benzinga Newsdesk January 30, 10:20 AM Morgan Stanley analyst Erin Wright maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underweight and lowers the price target from $39 to $37. WBA